Associated products


Our Abpromise guarantee covers the use of ab210532 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-ISG15 antibody (ab131119)

  • Form

  • Additional notes

    This is the blocking peptide for ab131119.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -20°C.

  • Reconstitution
    Reconstitute with 100ul of distilled water.

General Info

  • Alternative names

    • G1P2
    • hUCRP
    • IFI 15
    • IFI15
    • Interferon alpha inducible protein
    • Interferon induced protein 15
    • Interferon induced protein IFI-15K
    • Interferon stimulated protein 15 kDa
    • Interferon, alpha-inducible protein (clone IFI-15K)
    • Interferon-induced 15 kDa protein
    • Interferon-induced 17 kDa protein
    • Interferon-induced 17-kDa/15-kDa protein
    • IP17
    • ISG 15
    • ISG15
    • ISG15 ubiquitin like modifier
    • ISG15_HUMAN
    • Ubiquitin cross-reactive protein
    • Ubiquitin-like protein ISG15
    • UCRP
    see all
  • Function

    Ubiquitin-like protein that is conjugated to intracellular target proteins after IFN-alpha or IFN-beta stimulation. Its enzymatic pathway is partially distinct from that of ubiquitin, differing in substrate specificity and interaction with ligating enzymes. ISG15 conjugation pathway uses a dedicated E1 enzyme, but seems to converge with the Ub conjugation pathway at the level of a specific E2 enzyme. Targets include STAT1, SERPINA3G/SPI2A, JAK1, MAPK3/ERK1, PLCG1, EIF2AK2/PKR, MX1/MxA, and RIG-1. Deconjugated by USP18/UBP43. Shows specific chemotactic activity towards neutrophils and activates them to induce release of eosinophil chemotactic factors. May serve as a trans-acting binding factor directing the association of ligated target proteins to intermediate filaments. May also be involved in autocrine, paracrine and endocrine mechanisms, as in cell-to-cell signaling, possibly partly by inducing IFN-gamma secretion by monocytes and macrophages. Seems to display antiviral activity during viral infections.
    In response to IFN-tau secreted by the conceptus, may ligate to and regulate proteins involved in the release of prostaglandin F2-alpha (PGF), and thus prevent lysis of the corpus luteum and maintain the pregnancy.
  • Tissue specificity

    Detected in lymphoid cells, striated and smooth muscle, several epithelia and neurons.
  • Sequence similarities

    Contains 2 ubiquitin-like domains.
  • Cellular localization

    Cytoplasm. Secreted. UCRP conjugates seem to be noncovalently associated with the intermediate filaments and distributed in a punctate pattern. Also secreted.
  • Information by UniProt


ab210532 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab210532.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact

Sign up